SCHEMBL10467788

SCHEMBL10467788

CC(=O)Nc1ccc(CCCOCCCCCCNCC(O)c2cc(Cl)c(N)c(Cl)c2)nc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 1/20 0.52
▸ ADRB2 P07550 19/20 0.42
▸ ADRB3 P13945 16/20 0.42
▸ ADRB1 P08588 16/20 0.42
▸ MLNR O43193 1/20 0.38
▸ NR1I2 O75469 1/20 0.38
▸ ABCB11 O95342 1/20 0.38
▸ ADORA3 P0DMS8 1/20 0.38
▸ DRD1 P21728 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ MC3R P41968 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ SCN5A Q14524 1/20 0.38
▸ GHSR Q92847 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764359 0.86 ADRB2 (0.51) SLC2A1ADRB2ADRB3ADRB1
SCHEMBL10417733 0.85 SLC2A1 (0.52) SLC2A1ADRB2ADRB3ADRB1MLNR
SCHEMBL10467365 0.83 SLC2A1 (0.51) SLC2A1ADRB2ADRB3ADRB1MLNR
SCHEMBL10416519 0.81 SLC2A1 (0.59) SLC2A1ADRB2ADRB3ADRB1MLNR
SCHEMBL10418436 0.81 SLC2A1 (0.59) SLC2A1ADRB2ADRB3ADRB1MLNR
SCHEMBL10465946 0.80 SLC2A1 (0.60) SLC2A1ADRB2ADRB3ADRB1MLNR
SCHEMBL9741835 0.79 SLC2A1 (0.57) SLC2A1ADRB2ADRB3ADRB1MLNR
SCHEMBL10467798 0.79 SLC2A1 (0.53) SLC2A1ADRB2ADRB3ADRB1MLNR
SCHEMBL10466590 0.79 SLC2A1 (0.58) SLC2A1ADRB2ADRB3ADRB1MLNR
SCHEMBL9741406 0.79 SLC2A1 (0.51) SLC2A1ADRB2ADRB3ADRB1MLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4921867-A Pyridine compounds useful for therapy or prophylaxis of a disease associated with airway obstruction GLAXO GROUP LIMITED (GB) 1990-05-01 — — US disclosed
EP-0278728-A2 1-(4-Amino-3,5-dichlorophenyl)-2-(substituted amino)ethanol derivatives and their use in the treatment of respiratory disease GLAXO GROUP LIMITED (GB) 1988-08-17 — — EP disclosed
Send feedback